Hemostemix Financial Overview
Hemostemix's market cap is currently C$15.08M. The company's EPS TTM is C$-0.003; its P/E ratio is -2.75; Hemostemix is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
